Austria - Re-Imbursed Pharmaceutical Market
Since 2014, Austria Re-Imbursed Pharmaceutical Market increased 2.2points year on year. At 52.2 Percent of Generics in Value in 2019, the country was number 1 comparing other countries in Re-Imbursed Pharmaceutical Market. United Kingdom, Turkey and New Zealand respectively ranked number 2, 3 and 4 in this ranking. Denmark witnessed the best average annual growth at +6.9points per year, while Slovakia recorded the worst performance at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 52.20 |
| 2018 | 50.80 |
| 2017 | 50.20 |
| 2016 | 48.40 |
| 2015 | 47.50 |
Download all data from 2003 to 2019
How does Austria rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data |
| 3 |
#3
Turkey
|
36.20 % | 2019 | -3.7 % | +3.3 % | View data |
| 4 |
#4
New Zealand
|
33.10 % | 2019 | +1.2 % | +0.7 % | View data |
| 5 |
#5
Germany
|
32.90 % | 2019 | +1.5 % | -1.9 % | View data |